VASRD 7719 · Hemic and Lymphatic Systems
Chronic Myelogenous Leukemia (CML) at 60% VA Disability Rating
Data last updated September 23, 2026
Intermittent myelosuppressive therapy, or a tyrosine kinase inhibitor or interferon while not in apparent remission.
60% combined rating: single veteran, no dependents
$1,435.02
$17,220.24/year · tax-free · effective December 1, 2025
VA pays on the combined rating, not per condition: this is the amount when 60% is the veteran's combined rating, after all separate ratings are combined under 38 CFR 4.25.
The full 60% pay chart, with dependentsCombine this rating with others
VA Rating Criteria for 60%
Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission
60% Pay by Household (2026)
Monthly compensation at a 60% combined rating. Dependent additions apply at 30% and above.
| Single (no dependents) | $1,435.02 |
| With spouse | $1,566.02 |
| With spouse + 1 child | $1,663.02 |
| With spouse + 2 children | $1,728.02 |
| Single + 1 child (no spouse) | $1,523.02 |
Lower tier
30% Chronic Myelogenous Leukemia (CML)
$552.47 /mo single
Higher tier
100% Chronic Myelogenous Leukemia (CML)
$3,938.58 /mo single
Common questions about 60% for Chronic Myelogenous Leukemia (CML)
How much does a 60% VA rating for Chronic Myelogenous Leukemia (CML) pay?
VA pays on the combined rating, not per condition: this is the amount when 60% is the veteran's combined rating, after all separate ratings are combined under 38 CFR 4.25. At a 60% combined rating, a single veteran receives $1,435.02 per month ($17,220.24/year) under the 2026 VA rates, effective December 1, 2025. VA disability compensation is tax-free. With a spouse and one child, the monthly amount is $1,663.02.
What does it take to get a 60% rating for Chronic Myelogenous Leukemia (CML)?
Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission.
What's the difference between 60% and 100% for Chronic Myelogenous Leukemia (CML)?
60%: Requiring intermittent myelosuppressive therapy, or molecularly targeted therapy with tyrosine kinase inhibitors, or interferon treatment when not in apparent remission. 100%: Requiring peripheral blood or bone marrow stem cell transplant, or continuous myelosuppressive or immunosuppressive therapy treatment.
Official sources
- 38 CFR § 4.117, Schedule of ratings, hemic and lymphatic systems (Diagnostic Code 7719)
- VA.gov, 2026 veteran disability compensation rates, effective December 1, 2025
Pay amounts on this page were last checked against VA.gov on September 22, 2026.
How these figures are checked: our methodology and the open dataset.
See all rating tiers and evidence guidance
Full VASRD criteria, best evidence, exam pitfalls, and secondary conditions for Chronic Myelogenous Leukemia (CML) are on the main condition page.
View full Chronic Myelogenous Leukemia (CML) guideVA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline